Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study

Cousin, S; Blay, JY; Garcia, IB; de Bono, JS; Le Tourneau, C; Moreno, V; Trigo, J; Hann, CL; Azad, AA; Im, SA; Cassier, PA; French, CA; Italiano, A; Keedy, VL; Plummer, R; Sablin, MP; Hemming, ML; Ferron-Brady, G; Wyce, A; Khaled, A; Datta, A; Foley, SW; McCabe, MT; Wu, YH; Horner, T; Kremer, BE; Dhar, A; O’Dwyer, PJ; Shapiro, GI; Piha-Paul, SA – 2022